Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard ...

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action to increase access ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

A campaign led by a diabetes expert at the University of Exeter is aiming reduce plastic waste by encouraging patients and doctors to consider ...

Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

The company has two approved medical devices in China, namely reusable insulin injection pen (GanleePen), and disposable pen needle (GanleeFine®). In China's 2024 National Insulin-Specific Centralized ...

Increased number of diabetes cases is one of the key factors driving the market growth as injection pens are preferred due to their convenience, comfort and simplicity than other traditional methods.

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.